ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.